대한한방종양학회지 (THE JOURNAL OF KOREAN ORIENTAL ONCOLOGY)

대한암한의학회 (Korean Association of Traditional Oncology)
권호 표지

삼용부정탕(蔘茸扶正湯)의 방사선(放射線) 조사(照射)로 손상(損傷)된 조직(組織) 회부(恢復) 및 조혈촉진(造血促進) 효과(效果)

Hemopoietic and Radioprotective Effects of Shenrong Fuzheng Tang(S.F.T.;蔘茸扶正湯)

  • 김정수 (경희대학교 한의과대학 병리학교실) ;
  • 최승훈 (경희대학교 한의과대학 병리학교실) ;
  • 안규석 (경희대학교 한의과대학 병리학교실)
  • 발행 : 1997.12.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

현재 서양의학에서 활용되고 있는 항암 요법으로는 외과처치(外科處置), 화학요법(化學療法), 방사선요법(放射線療法) 및 면역요법(免疫療法) 등(等)이 있으며, 그 중에서도 항암제(抗癌劑)에 의한 화학요법과 방사선요법이 가장 많이 응용되고 있다. 그런데 이들은 암세포(癌細胞)뿐만 아니라 정상세포(正常細胞)까지도 살상(殺傷)함으로써 종양세포(腫瘍細胞)를 억제하는 동시에 골수조혈기(骨髓造血器), 소화계통(消化系統) 및 면역기능(免疫機能)을 포함하는 인체의 정상적인 기능을 손상시키는 문제점으로 그 사용에 제한을 받고 있다. 따라서, 본 연구는 삼용부정탕(蔘茸扶正湯)의 항암요법으로 손상된 조직의 회복 및 조혈촉진 효과를 규명하기 위해 생쥐를 대상으로 하여 실험하였다. 그 결과, 생쥐 비장세포에 대한 증식효과(增殖效果), 조혈촉진인자(造血促進因子)의 분필능(分泌能), 방사선에 대한 임파구의 방어효과(防禦效果), 방사선에 대한 조혈세포 방어효과(防禦效果), 방사선(9Gy)을 조사받은 생쥐의 생존율(生存率) 등에서 유의성 있는 결과를 얻어내어 아래와 같이 보고하는 바이다.

Radiotherapy is an irreplaceable method of cancer treatment. But it has several side effects, especially damages to the hemopoietic and Immune system. Therefore radioprotectors are required to treat cancer successfully. A lot of Herbs and Herbal prescriptions are reported to have radioprotective effects. Above all, those to support the healthy energy and strengthen the body resistance are found more effective. This study was performed to evaluate the radioprotective effects of prescription Shenrong Fuzheng Tang(S.F.T.), which consists of 16 kinds of herbs. We investigated proliferation of murine splenocytes, secretion of colony-stimulating-factors(CSFs), immunocompetence after irradiation in-vitro, and Endogenous spleen colony assay, survival assay in-vivo. When splenocytes were cultured with Shenrong Fuzheng $Tang(S.F.T.)(500{\mu}g/ml)$, proliferation was enhanced 5.7 times compared to control cultured with medium alone(p<0.05) and, showed highest proliferation at 4th day after incubation. In order to evaluate stimulation of hemopoiesis of Shenrong Fuzheng Tang(S.F.T.), the supernatant of splenocytes cultured with optimal concentration of Shenrong Fuzheng Tang(S.F.T.) was used to measure CSFs secretion. The result showed enhanced secretion of colony-stimulating-factors (CSFs) compared to control(p<0.05). To evaluate the protective effect of lymphocytes from irradiation, proliferation of splenocytes stimulated by LPS and ConA after incubation with Shenrong Fuzheng Tang(S.F.T.) for 24h Prior to Irradiation$(1{\sim}3\;Gy)$ was measured. The results showed higher proliferation of Shenrong Fuzheng Tang(S.F.T.) treated cells than that of non-treated cells. And percentage increases of irradiated splenocytes per non-irradiated splenocytes were also higher in Shenrong Fuzheng Tang (S.F.T.)-treated cells than control. Endogenous spleen colony assay. to evaluate the protection of hemopoietic cells from irradiation, showed increased number of colonies(p=0.03) in Shenrong Fuzheng Tang(S.F.T.) treated murine spleen$(10.3{\pm}1.9)$ compared to non-treated murine spleen$(3.4{\pm}0.8)$. Survival time of mice irradiated with lethal dose of ${\gamma}-ray(9Gy)$ was prolonged in Shenrong Fuzheng Tang(S.F.T.) treated group prior to irradiation as compared to non-treated group. According to these results we can suggest that prescription Shenrong Fuzheng Tang(S.F.T.) has radioprotective effects and can be used to protect the hemopoietic and immune system from damages of anti-cancer radiotherapy.

키워드

참고문헌

  1. 濟衆新編 康命吉
  2. 臟附辨證論治 金完熙;崔達永
  3. 東醫腎系內科學 杜鎬京(編)
  4. 臟象學 朴贊國(編譯)
  5. 임상약학 v.6 no.1 암의 약물치료 백남선
  6. 종양학 서울대학교 의과대학
  7. 생리학 제5판 성호경;이상돈
  8. 東醫病理學 安圭錫;崔昇勳;文濬典(外)
  9. 醫宗金鑑 吳謙
  10. 內科學 李文鎬(外)
  11. 本草學 全國韓醫科大學 本草學敎室
  12. 醫門寶鑑 周命新
  13. 東醫腫瘍學 崔昇勳
  14. 이우주의 약리학강의 홍사석
  15. 大韓韓醫學會誌 v.10 癌의 治療, 治方에 關한 文獻的 考察 金韓燮(等)
  16. 병리학회지 v.9 항암제 및 방사선 부작용에 대한 한방요법 김동희;김성훈
  17. 大田大學校 碩士學位論文 消積白朮散이 白鼠의 抗癌障碍에 미치는 影響 白承學
  18. 과기처시행특정연구 개발사업 연구결과문 방사선에 의한 인체장해연구 윤택구
  19. 大田大學校 碩士學位論文 蔘茸湯이 S-180에 對한 抗腫瘤 效果와 cyclophospha mide에 依한 副作用減少에 미치는 影響 張中植
  20. 제1회 동양의학 국제심포지움논문집 放射線 照射後의 N;GP(S) mouse 脾臟細胞 增殖에 미치는 補中益氣湯과 四六湯의 效果 崔昇勳
  21. 慶熙大學校 大學院 博士學位論文 蔘령白朮散의 抗癌劑 副作用 抑制에 關한 實驗的 硏究 韓承燮
  22. 瘍醫大全 顧世澄
  23. 薛氏醫案(全 2券 中) 薛己
  24. 諸病源候論 巢元方
  25. 備急千金要方 孫思邈
  26. 癌症腫瘤醫論醫話精選 扶正培本法治療惡性腫瘤的硏究 王錦雲
  27. 外科證治全生集 王維德
  28. 腫瘤硏究 郁仁存
  29. 中醫腫瘤學 郁仁存
  30. 黃帝內經章句索引 任應秋(外)
  31. 張氏醫通 張로
  32. 三因極一病證方論 v.8;13;15 陳言
  33. 中國中藥雜誌 v.3 補中益氣湯對環린선안抗癌活性和毒性的影響 李宇彬
  34. 癌症腫瘤醫論醫話精選 中醫配合化學藥物治療腫瘤的體會 貝潤浦
  35. 中醫雜誌 在惡性腫瘤治療中如何合理應用活血化瘀藥物 邱佳信
  36. 陜西中醫 v.11 中藥防治腫瘤化療毒副反應209例臨床觀察 金光(外)
  37. 浙江中醫雜誌 v.1 降逆湯防治腫瘤化療消化道反應三十七例 徐梅文
  38. 대한의학협회지 v.32 no.3 최근 한국의 질병 변천 이문호 등
  39. 新中醫 v.2 參射湯治療鼻咽癌中不良反應的臨床觀察 吳敬亮
  40. Science v.236 The human colony stimulating factors Clark, S.;Kamen, R.
  41. Radiation research v.128 Radiation sensitivity of the hemopoietic stem cell D.W. Van Bekkum
  42. Principles and practice of radiation oncology Morphology of radiation effects on normal tissues Fajardo, L.F.
  43. Methods in immunotoxicology v.1 Gray, R. Burleson.;Jack, H. Dean.;Albert, E. Munson.
  44. Inter. J. Radiat. Biol. v.63 no.1 Residual hemopoietic damage in adult and 8-day-old mice exposed to 7Gy of X-rays Grande, T.;Gaitan, S.;Tejero, C.;Bueren, J.A.
  45. Cancer Research. v.47 Response of drug sensitive and resistant L1210 Leukemias to high-dose chemotherapy Griswold, D.P. Jr.;Trader, M.W.;Frei, E. III.;Peters, W.P.;Wolper, M.K.;Laster, W.R. Jr.
  46. The basic science of oncology Hill, R.P.;Tannock, I.F.(eds);Hill, E.P.
  47. J. Medical and Pharmaceutical Society for Wakan-Yaku v.3 Radioprotective effects of Chinese medicinal prescriptions in mice Hosokawa, Y.
  48. American J. Chinese medicine v.11 no.3-4 Effects of Jen-Sheng-Yang-Yung-Tang on Cellular Immunocompetence of $\gamma$-irradiated Mice Hsu, H.Y.;Hau, D.M.;Lin, C.C.
  49. American J. Chinese medicine v.11 no.2 Effects of Kuei-Pi-Tang on Cellular Immunocompetence of $\gamma$-irradiated Mice Hsu, H.Y.;Hau, D.M.;Lin, C.C.
  50. Cecil textbook of medicine James,B.;Lyoyd, H.
  51. Seminars in Hematology v.28 no.2 Culture of hematopoietic stem cells purified from murin bone marrow Jan, W.M.Visser;Dries H. Mulder.
  52. Biological Radiation Effect Jurgen Kiefer
  53. J. Immunol. v.145 Radioprotective Effects of The Immunomodulator A101 Kalechman, Y.;Alveck, M.;Oron, M.;Sobelman, D.;Gurwith, M.;Seghal, S.N.;Sedni, B.
  54. Exp. Hematol. v.9 The ultrastructure of the hemopoietic environment of the bone marrow: A review. Lichtman, M.
  55. Int. J. Cloning v.7 Radiobiological properties of human hematopoietic and stromal marrow cells Laver, J.
  56. Rad. Res. v.137 Protection from Lethal Irradiation by the Combination of Stem cell Factor and Tempol LieMann, J.;DeLuca, A.M.;Epstein, A.;Steinberg, S.M.;Morstyn, G.;Mitchell. B.
  57. Health Physics v.59 T cell potentiation by low dose ionizing radiation : possible mechanisms Makinodan, T.;James, S.J.
  58. Cancer Res. v.20 Phytohemagglutinin:an inhibitor of mitosis in cultures of normal human leukocytes Nowell, P.C.
  59. Lymphokine Res v.5 no.sup.11 Cytokines in radioprotection: comparison of the radioprotective effects of IL-1 toIL-2, GM-CSF and IFN-$\gamma$ Neta, R.;Vogel, S.N.;Oppenheim. J.J.;Douches, S.D.
  60. Pharmac. Ther. v.50 The potential importance of Swanisonine in therapy for cancers and immunology Olden, K.;Breton, P.;Grzegorzewski, K.;Yasuda, T.;Gause, B.;Oredipe, O.A.;Newton, S.A.;White, S.L.
  61. Immunology v.5 Action of ionizing radiation on lymphocytes(inhibition and activation effects) Yarilin, A.A.
  62. Health Physics v.59 T cell potentiation by low dose ionizing radiation: possible mechanisma Makinodan, T.;James, S.J.
  63. Cancer Res. v.20 Phytohemagglutinin : an inhibitor of mitosis in culture of normal human leukocytes Nowell, P.C.
  64. Lymphokine Res. v.5 no.SUP.11 Cytokines in radioprotention : comparison of the radioprotective effects of IL-1 to IL-2, GM-CSF and IFN-$\gamma$ Olden, K.;Breton, P.;Grezegorzewski, K.;Yasuda, T.;Gause, B.;Oredipe, O.A.;Newton, S.A.;White, S.L.
  65. Immunology v.5 Action of ionizing radiation on lymphocytes(inhibition and activation effects) Yarilin, A.A.
  66. Pharmac. Ther. v.50 The potential importance of Swanisonine in therapy for cancers and immunology Olden, K.;Breton, P.;Grezegorzewski, K.;Yasuda, T.;Gause, B.;Oredipe, O.A.;Newton, S.A.;White, S.L.